Details of the Drug

General Information of Drug (ID: DMH32LC)

Drug Name

ISIS-DMPK

Indication

Disease Entry	ICD 11	Status	REF
Myotonic dystrophy	8C71.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Antisense drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT02312011) A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.